Farms.com Home   News

Deadline for Atrazine Comments Has Arrived - Producers Encouraged To Let Their Voice Be Heard

The National Corn Grower Association is asking farmers to express their support for the herbicide atrazine at www.ncga.com/atz before the Oct. 5, 2016 deadline.

"Atrazine is a safe and effective crop management tool, and EPA should base their decisions on sound science," said National Corn Growers Production and Stewardship Action Team Chairman Brent Hostetler, a farmer from Plain City, Ohio. "That's why I'm urging farmers to contact the EPA and make their voices heard."

Farming without atrazine could cost farmers up to $59 per acre, according to a 2012 analysis by the University of Chicago. That could mean the difference between corn farmers making a profit or loss on their crop. Atrazine, a key ingredient in nearly 100 herbicide mixes farmers use, is one of the best tools on the market today for combatting resistant weeds that waste water and nutrients.

As part of the draft ecological risk assessment, EPA recommends reducing the aquatic life level of concern (LOC) from 10 parts per billion (ppb) on a 60-day average, to 3.4 ppb. Scientific evidence points to a safe aquatic life LOC at 25 ppb or greater. If this recommendation holds, it would result in a de facto ban on atrazine.
 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.